PDB Reduces Saxagliptin-Induced APD Prolongation in Cardiomyocytes

Medical University of Graz
Department of Cardiology
Postdoctoral Researcher

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Tocris Bioscience

Product Name:

Phorbol 12,13-dibutyrate

Catalog Number:

4153/1

Guinea pig ventricular cardiomyocytes were patched and superfused with Saxagliptin (2 µM, 5 min) followed by Phorbol 12,13-dibutyrate (PDB, 10 nM, 5 min) and action potentials were stimulated at a 1 Hz frequency. Action potential duration (APD) were analysed at 20%, 50%, and 90% repolarization (shown in Image). PDB reduced saxagliptin-induced APD prolongation.

Experimental Design and Results Summary

Application

Cardiac electrophysiology

Starting Material

Primary ventricular cardiomyocytes

Protocol Overview

Guinea pig ventricular cardiomyocytes were patched and superfused with Saxagliptin (2 µM, 5 min) followed by Phorbol 12,13-dibutyrate (PDB, 10 nM, 5 min) and action potentials were stimulated at a 1 Hz frequency.

Tips

N/A

Results Summary

Action potential duration (APD) were analysed at 20%, 50% and 90% repolarization (shown in Image). PDB reduced saxagliptin-induced APD prolongation.

DOI or PMID #

N/A

Additional Notes

N/A

Related Categories

Image Gallery

Summary

The Good

Easy to handle

The Bad

N/A

The Bottom Line

PDB reduces saxagliptin-induced APD prolongation in cardiomyocytes.

Join the discussion